These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19804709)

  • 1. Guidelines for submitting adverse event reports for publication.
    Kelly W; Arellano F; Barnes J; Bergman U; Edwards R; Fernandez A; Freedman S; Goldsmith D; Huang K; Jones J; McLeay R; Moore N; Stather R; Trenque T; Troutman W; van Puijenbroek E; Williams F; Wise R; ;
    Therapie; 2009; 64(4):289-94. PubMed ID: 19804709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards IR; Fernandez AM; Freedman SB; Goldsmith DI; Huang K; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):581-7. PubMed ID: 17471601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards RI; Fernandez AM; Freedman SB; Goldsmith DI; Huang KA; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Drug Saf; 2007; 30(5):367-73. PubMed ID: 17472416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.
    Impicciatore P; Mucci M
    Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
    Jacobsson I; Jönsson AK; Gerdén B; Hägg S
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1039-47. PubMed ID: 19650152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of suspected adverse reactions to natural health products in Italy.
    Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of the spanish pharmacovigilance system recommendations on the publication of cases of adverse drug reaction].
    Esteban Calvo C; Ibáñez Ruiz C; Salgueiro Vázquez E; Manso Rodríguez G
    Aten Primaria; 2008 Nov; 40(11):555-8. PubMed ID: 19055896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
    Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
    Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009.
    Patel DN; Low WL; Tan LL; Tan MM; Zhang Q; Low MY; Chan CL; Koh HL
    Clin Toxicol (Phila); 2012 Jul; 50(6):481-9. PubMed ID: 22738039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects associated with herbal medicine.
    Pinn G
    Aust Fam Physician; 2001 Nov; 30(11):1070-5. PubMed ID: 11759460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern and quality of scientific communications on drug safety produced by a regional pharmacovigilance center in Nepal.
    Palaian S; Ibrahim MI; Mishra P
    Pharm Pract (Granada); 2010 Jul; 8(3):179-86. PubMed ID: 25126138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of published adverse drug event reports.
    Kelly WN
    Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
    Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
    Bohn J; Kortepeter C; Muñoz M; Simms K; Montenegro S; Dal Pan G
    Clin Pharmacol Ther; 2015 May; 97(5):508-17. PubMed ID: 25670505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.